WO2005072066A1 - 糖尿病黄斑症の予防又は治療剤 - Google Patents

糖尿病黄斑症の予防又は治療剤

Info

Publication number
WO2005072066A1
WO2005072066A1 PCT/JP2005/001187 JP2005001187W WO2005072066A1 WO 2005072066 A1 WO2005072066 A1 WO 2005072066A1 JP 2005001187 W JP2005001187 W JP 2005001187W WO 2005072066 A1 WO2005072066 A1 WO 2005072066A1
Authority
WO
WIPO (PCT)
Prior art keywords
preventive
therapeutic agent
diabetic maculopathy
diabetic
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2005/001187
Other languages
English (en)
French (fr)
Other versions
WO2005072066A3 (ja
WO2005072066A2 (ja
Inventor
Noriaki Kato
Hiroshi Nagano
Kaori Taniko
Takahito Jomori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanwa Kagaku Kenkyusho Co Ltd
Original Assignee
Sanwa Kagaku Kenkyusho Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to KR1020067015812A priority Critical patent/KR101111411B1/ko
Priority to AU2005207906A priority patent/AU2005207906B2/en
Priority to AT05704239T priority patent/ATE555117T1/de
Priority to DK05704239.2T priority patent/DK1719774T3/da
Priority to JP2005517502A priority patent/JP4014053B2/ja
Priority to CA2554679A priority patent/CA2554679C/en
Priority to US10/587,320 priority patent/US7910615B2/en
Priority to PL05704239T priority patent/PL1719774T3/pl
Priority to ES05704239T priority patent/ES2386094T3/es
Priority to EP05704239A priority patent/EP1719774B1/en
Application filed by Sanwa Kagaku Kenkyusho Co Ltd filed Critical Sanwa Kagaku Kenkyusho Co Ltd
Publication of WO2005072066A1 publication Critical patent/WO2005072066A1/ja
Publication of WO2005072066A2 publication Critical patent/WO2005072066A2/ja
Publication of WO2005072066A3 publication Critical patent/WO2005072066A3/ja
Anticipated expiration legal-status Critical
Priority to US12/842,391 priority patent/US8097640B2/en
Ceased legal-status Critical Current

Links

PCT/JP2005/001187 2004-01-30 2005-01-28 糖尿病黄斑症の予防又は治療剤 Ceased WO2005072066A2 (ja)

Priority Applications (11)

Application Number Priority Date Filing Date Title
ES05704239T ES2386094T3 (es) 2004-01-30 2005-01-28 Agente terapéutico para el edema macular diabético
AT05704239T ATE555117T1 (de) 2004-01-30 2005-01-28 Therapeutisches mittel gegen diabetisches makulaödem
DK05704239.2T DK1719774T3 (da) 2004-01-30 2005-01-28 Terapeutisk middel mod diabetisk makulaødem
JP2005517502A JP4014053B2 (ja) 2004-01-30 2005-01-28 糖尿病黄斑症の予防又は治療剤
CA2554679A CA2554679C (en) 2004-01-30 2005-01-28 Prophylactic or therapeutic agent for diabetic maculopathy
US10/587,320 US7910615B2 (en) 2004-01-30 2005-01-28 Prophylactic or therapeutic agent for diabetic maculopathy
PL05704239T PL1719774T3 (pl) 2004-01-30 2005-01-28 Środek do leczenia cukrzycowego obrzęku plamki
KR1020067015812A KR101111411B1 (ko) 2004-01-30 2005-01-28 당뇨병성 황반증의 예방 또는 치료제
AU2005207906A AU2005207906B2 (en) 2004-01-30 2005-01-28 Preventive or therapeutic agent for diabetic maculopathy
EP05704239A EP1719774B1 (en) 2004-01-30 2005-01-28 Therapeutic agent for diabetic macular edema
US12/842,391 US8097640B2 (en) 2004-01-30 2010-07-23 Prophylactic or therapeutic agent for diabetic maculopathy

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004022547 2004-01-30
JP2004-022547 2004-01-30

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US10/587,320 A-371-Of-International US7910615B2 (en) 2004-01-30 2005-01-28 Prophylactic or therapeutic agent for diabetic maculopathy
US12/842,391 Continuation US8097640B2 (en) 2004-01-30 2010-07-23 Prophylactic or therapeutic agent for diabetic maculopathy

Publications (3)

Publication Number Publication Date
WO2005072066A1 true WO2005072066A1 (ja) 2005-08-11
WO2005072066A2 WO2005072066A2 (ja) 2005-08-11
WO2005072066A3 WO2005072066A3 (ja) 2005-10-06

Family

ID=34823835

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2005/001187 Ceased WO2005072066A2 (ja) 2004-01-30 2005-01-28 糖尿病黄斑症の予防又は治療剤

Country Status (12)

Country Link
US (2) US7910615B2 (ja)
EP (1) EP1719774B1 (ja)
JP (2) JP4014053B2 (ja)
KR (1) KR101111411B1 (ja)
CN (1) CN100537574C (ja)
AT (1) ATE555117T1 (ja)
AU (1) AU2005207906B2 (ja)
CA (1) CA2554679C (ja)
DK (1) DK1719774T3 (ja)
ES (1) ES2386094T3 (ja)
PL (1) PL1719774T3 (ja)
WO (1) WO2005072066A2 (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006325947B2 (en) 2005-12-16 2011-09-01 Hirosaki University Agent for prevention and treatment of acute renal failure
AU2007218709A1 (en) * 2006-02-20 2007-08-30 Sanwa Kagaku Kenkyusho Co., Ltd. Prophylactic or therapeutic agent for cerebral ischemia or cerebral ischemic reperfusion injury in stroke
US8536212B2 (en) 2007-01-31 2013-09-17 Sanwa Kagaku Kenkyusho Co., Ltd. Protective agent for retinal nerve or optic nerve
JP5248477B2 (ja) * 2007-03-07 2013-07-31 杏林製薬株式会社 グルコキナーゼ活性化物質
ES2468827T3 (es) * 2010-01-14 2014-06-17 Sanwa Kagaku Kenkyusho Co., Ltd Producto farmacéutico para prevenir o tratar trastornos acompañados de angiog�nesis ocular y/o permeabilidad vascular ocular elevada
AU2011246232A1 (en) 2010-04-28 2012-11-01 Sanwa Kagaku Kenkyusho Co., Ltd. Prophylactic or therapeutic medication for inner ear disorders
RU2438637C1 (ru) * 2010-07-13 2012-01-10 Государственное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия Федерального Агентства по здравоохранению и социальному развитию" (ГОУ ВПО "НижГМА Росздрава") Способ лечения диабетического макулярного отека
EP2671589A4 (en) * 2011-02-02 2014-11-19 Public Univ Corp Nagoya City Univ MEDICAMENT FOR PREVENTING OR TREATING DISEASES RELATED TO INTRAOCULAR NEOVASCULARIZATION AND / OR INTRAOCULAR VASCULAR HYPERPERMEABILITY
JP2015110525A (ja) * 2012-04-02 2015-06-18 株式会社三和化学研究所 歯肉炎の予防又は治療のための医薬
JP6187985B2 (ja) * 2015-07-14 2017-08-30 国立大学法人佐賀大学 ノックアウト非ヒト動物
CN120615922B (zh) * 2025-06-20 2025-12-23 广东省农业科学院植物保护研究所 阿脲在用于防治粮食作物真菌病害中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61200991A (ja) 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk スピロ―３―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤
JP2672949B2 (ja) 1987-10-20 1997-11-05 株式会社芝浦製作所 エミッションコントロール装置
JP2976230B2 (ja) * 1989-12-20 1999-11-10 大塚製薬株式会社 糖尿病ラット
JP3025917B2 (ja) * 1990-12-19 2000-03-27 大塚製薬株式会社 インシュリン非依存性糖尿病ラット
US5639482A (en) * 1993-11-10 1997-06-17 Crary; Ely J. Composition for control and prevention of diabetic retinopathy
JPH07242547A (ja) * 1994-03-02 1995-09-19 Sanwa Kagaku Kenkyusho Co Ltd 糖尿病性単純網膜症の進行阻止剤乃至治療剤
JP3072226B2 (ja) * 1994-06-20 2000-07-31 日本原子力研究所 デカボランガス供給システムにおけるデカボラン供給方法
DE69519219T2 (de) 1994-12-28 2001-02-22 Sanwa Kagaku Kenkyusho, Co. Verwendung von (2S,4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazoline]-2-carboxamid zur Behandlung von Keratopathie
JP3603129B2 (ja) 1994-12-28 2004-12-22 株式会社三和化学研究所 糖尿病性角膜症の治療剤
JPH09301861A (ja) * 1996-05-13 1997-11-25 Showa Denko Kk ラジカル疾患用注射・点滴薬剤
JP4588808B2 (ja) * 1996-11-01 2010-12-01 塩野義製薬株式会社 ヒト疾患モデルマウス
US6479729B1 (en) * 1998-02-06 2002-11-12 The Johns Hopkins University Mouse model for ocular neovascularization
CA2319798C (en) * 1998-02-06 2009-09-29 Cci Corporation Agent for preventing and curing hindrance of ischemic reperfusion
JP2000270713A (ja) * 1999-03-23 2000-10-03 Kennetto:Kk 糖尿病態モデル動物及びその製造方法並びに糖尿病態モデル動物の選定方法
US6426341B1 (en) * 1999-06-30 2002-07-30 Pfizer Inc. Treatment for diabetic complications
EP1106210A3 (en) * 1999-12-07 2003-12-03 Pfizer Products Inc. Combination of aldose reductase inhibitors and antihypertensive agents for the treatment of diabetic complications

Similar Documents

Publication Publication Date Title
TW200637839A (en) 1-thio-d-glucitol derivatives
ES2311530T3 (es) Combinaciones farmaceuticas para el tratamiento y la prevencion de la diabetes mellitus.
WO2005072066A3 (ja) 糖尿病黄斑症の予防又は治療剤
WO2005072066A1 (ja) 糖尿病黄斑症の予防又は治療剤
MX2007000028A (es) Derivados de nicotinamida y su uso como agentes terapeuticos.
EP1792927A4 (en) NEW BLOCK COPOLYMER, MICELLA PREPARATION AND ANTICROPHIDE CONTAINING THIS AS ACTIVE INGREDIENTS
NO20070295L (no) Nye CIS-imidazoliner
PT1780197E (pt) 5-substituinte-2-fenilamino benzamida como inibidor de mek
KR20010033092A (ko) 발기부전 치료에 효과적인 조합물
PE20051164A1 (es) Compuestos de 5, 6-dialquil-7-amino-triazolopirimidinas
US6436944B1 (en) Combination effective for the treatment of impotence
WO2008093691A1 (ja) 網膜神経又は視神経の保護剤
TW200745136A (en) 4-Amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives
WO2005117542A3 (en) Treatment of pancreatic cancer with active vitamin d compounds in combination with other treatments
EA039683B1 (ru) ФОСФОРСОДЕРЖАЩИЕ ПРОЛЕКАРСТВА СТИМУЛЯТОРОВ sGC
AR069857A1 (es) Derivados de piridazina y procesos de obtencion
EP1391452A4 (en) 4-HYDROXPIPERIDIN DERIVATIVE ANALGETIC EFFECT
WO2006125194A3 (en) Piperazine derivatives and their uses as therapeutic agents
KR20210072062A (ko) 말라세지아-유래 화합물 및/또는 이의 화학적 유사체를 함유하는 광보호 조성물
AU695907B2 (en) Pharmaceutical composition for prophylaxis and treatment of type I allergic diseases
DE60126199D1 (de) Therapeutische behandlung von eosinophilie durch verwendung von chymase-inhibitoren als aktiven bestandteilen
CA2411418A1 (en) Hydroxyformamidine derivatives and medicines containing the same
ATE303145T1 (de) Arzneimittel enthaltend einen effektor des glutathionmetabolismus (ambroxol) zusammen mit alpha-liponsäure im rahmen der behandlung des diabetes mellitus
KR102105533B1 (ko) 아마이드 유도체 화합물
AU7424394A (en) 3- or 4-glycosyloxybenzopyran derivatives and antiallergic agents containing the derivatives as active ingredients